Page last updated on July 16, 2024
Mosaic ImmunoEngineering Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-15 15:42:30 EDT.
Filings
10-K filed on 2024-04-15
Mosaic ImmunoEngineering Inc. filed a 10-K at 2024-04-15 15:42:30 EDT
Accession Number: 0001683168-24-002402
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
ITEM 1C. CYBERSECURITY Risk Management and Strategy We recognize the importance of assessing, identifying, and managing material risks associated with cybersecurity threats, as such term is defined in Item 106(a) of Regulation S-K. These risks include, among other things: operational risks, intellectual property theft, fraud, extortion, harm to employees or customers and violation of data privacy or security laws. While do not presently have any general processes for assessing, identifying, and managing material risks from cybersecurity threats due to our limited financial resources, we do oversee certain third-party service providers and we plan to institute broader cybersecurity measures at such time we are able to raise sufficient capital. 27 Oversee Third-party Risk Because we are aware of the risks associated with third-party service providers, we oversee and manage these risks by monitoring these third-party service providers and reviewing SOC reports of these providers and implementing complementary controls, if necessary. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third parties. Risks from Cybersecurity Threats We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing.
Company Information
Name | Mosaic ImmunoEngineering Inc. |
CIK | 0000836564 |
SIC Description | Biological Products, (No Diagnostic Substances) |
Ticker | CPMV - OTC |
Website | |
Category | Non-accelerated filer Smaller reporting company |
Fiscal Year End | December 30 |